Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery

Annals of Vascular Surgery

Volumn 25, Issue 6, 2011, Pages 813-822

  Saha, Sibu P ^a   Muluk, Satish ^b   Schenk III, Worthington ^c   Burks, Sandra G ^c   Grigorian, Ani ^d   Ploder, Bettina ^e   Presch, Isabella ^e   Pavlova, Borislava G ^e   Hantak, Edith ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d BAXTER HEALTHCARE CORPORATION   (United States)

^e BAXTER BIOSCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; FIBRIN GLUE; HEPARIN; PROTAMINE; THROMBIN;

ADULT; AGED; ARTICLE; BLEEDING; CLAMP; COMPRESSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GAUZE DRESSING; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; POLITEF IMPLANT; POLYMERIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VASCULAR SUTURE;

AGED; BLOOD LOSS, SURGICAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOSTATIC TECHNIQUES; HEMOSTATICS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYTETRAFLUOROETHYLENE; PRESSURE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SUTURE TECHNIQUES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79960977280     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2010.12.016     Document Type: Article

References (19)

1. Milne AA, Murphy WG, Reading SJ, Ruckley CV. Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomised trial. Eur J Vasc Endovasc Surg 1995;10:91-94.
2. Sabovic M, Salobir B, Preloznik ZI, et al. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis. Pathophysiol Haemost Thromb 2005;34:274-278. (Pubitemid 43882426)
3. Spotnitz WD, Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008;48: 1502-1516.
4. Schenk WG III, Burks SG, Gagne PJ, et al. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003;237:871-876. (Pubitemid 38174523)
5. Schenk WG III, Goldthwaite CA Jr, Burks S, Spotnitz WD. Fibrin sealant facilitates hemostasis in arteriovenous polytetrafluoroethylene grafts for renal dialysis access. Ann Surg 2002;68:728-732. (Pubitemid 44971238)
6. Schenk WG III, Spotnitz WD, Burks SG, et al. Absorbable cyanoacrylate as a vascular hemostatic sealant: a preliminary trial. Ann Surg 2005;71:658-661. (Pubitemid 43942966)
7. Unlu Y, Vural U, Kocak H, et al. Comparison of the topical haemostatic agents for the prevention of suture hole bleeding. An experimental study. Eur J Vasc Endovasc Surg 2002;23:441-444. (Pubitemid 41079427)
8. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972;176:321-333.
9. Milne AA, Murphy WG, Reading SJ, Ruckley CV. A randomised trial of fibrin sealant in peripheral vascular surgery. Vox Sang 1996;70:210-212. (Pubitemid 26161429)
10. Sintler MP, Mahmood A, Smith SR, et al. Randomized trial comparing Quixil surgical sealant with Kaltostat hemostatic dressing to control suture line bleeding after carotid endarterectomy with ePTFE patch reconstruction. World J Surg 2005;29:1259-1262. (Pubitemid 41625969)
11. Czerny M, Verrel F, Weber H, et al. Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg (Torino) 2000;41:553-557.
12. Tredree R, Beierlein W, Debrix I, et al. Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists. Eur J Hosp Pharm Sci 2006;12:3-9.
13. Tawil B. Fibrin and its applications. In: Guelcher SA, Hollinger JO eds. An Introduction to Biomaterials. Boca Raton, FL: CRC, 2006. pp 105-120.
14. Silecchia G, Boru CE, Mouiel J, et al. The use of fibrin sealant to prevent major complications following laparoscopic gastric bypass: results of a multicenter, randomized trial. Surg Endosc 2008;22:2492-2497.
15. Guideline on the clinical investigation of Plasma derived Fibrin Sealant/Haemostatic Products (CPMP/BPWG/1089/00), London, July 29, 2004. Available at: www.ema. europa.eu.
16. Di Minno MN, Prisco D, Ruocco AL, et al. Perioperative handling of patients on antiplatelet therapy with need for surgery. Intern Emerg Med 2009;4:279-288.
17. Burdess A, Nimmo AF, Garden OJ, et al. Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg 2010;252:37-42.
18. Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 2005;79: 1454-1461. (Pubitemid 40431898)
19. Borst HG, Haverich A, Walterbusch G, Maatz W. Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 1982;84: 548-553. (Pubitemid 14213462)